Regulatory Pathways for Cell and Gene Therapies: Balancing Innovation with Compliance

被引：0

|

作者：

Bernard, Claire ^{[1
]}

机构：

[1] Institute of Biotechnology, Université de Bordeaux, Bordeaux, France

来源：

Journal of Commercial Biotechnology | 2024年 / 29卷 / 06期

关键词：

Compilation and indexing terms; Copyright 2025 Elsevier Inc;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Disease control - Diseases - Regenerative medicine

引用

收藏

页码：136 / 144

相关论文

共 50 条

[21] Industrializing cell and gene therapies
Shanley, Agnes
Pharmaceutical Technology, 2019, 2019 (04)
[22] The Rise of Cell and Gene Therapies
Hilas, Olga
US PHARMACIST, 2024, 49 (10)
[23] TRANSLATION OF CELL AND GENE THERAPIES
Narayanan, G.
CYTOTHERAPY, 2016, 18 (06) : S23 - S23
[24] Autologous cell therapies: the importance of regulatory oversight
Werner, Michael
Mayleben, Tim
Van Bokkelen, Gil
REGENERATIVE MEDICINE, 2012, 7 (06) : 100 - 103
[25] Regulatory Considerations in Application of Encapsulated Cell Therapies
van Zanten, J.
de Vos, Paul
THERAPEUTIC APPLICATIONS OF CELL MICROENCAPSULATION, 2010, 670 : 31 - 37
[26] Gene and cell therapies in demand
King, Anthony
CHEMISTRY & INDUSTRY, 2019, 83 (05) : 8 - 8
[27] Gene and stem cell therapies
Kaji, EH
Leiden, JM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05): : 545 - 550
[28] Industrializing Cell and Gene Therapies
Shanley, Agnes
BIOPHARM INTERNATIONAL, 2019, 32 (08) : 10 - +
[29] Gene and Cell Based Therapies
Barker, R.
MOVEMENT DISORDERS, 2010, 25 : S598 - S599
[30] Subversion of cell cycle regulatory pathways
Sanchez, V.
Spector, D. H.
HUMAN CYTOMEGALOVIRUS, 2008, 325 : 243 - 262

← 1 2 3 4 5 →